Balance Rehabilitation Based on Serious Games
BERTHA
Efficacy of BalancE RehabiliTation Based on Serious Games in People With Hip Arthroplasty: a Pilot Non-Randomized Multicenter Study
1 other identifier
interventional
20
1 country
2
Brief Summary
The effects of new technologies, particularly exergames, on the rehabilitation process of patients with hip arthroplasty have not yet been verified. For this reason, the aim of this study is to evaluate the effectiveness, in terms of balance recovery, of a balance rehabilitation program based on serious games in individuals with hip arthroplasty compared to conventional treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2023
CompletedFirst Submitted
Initial submission to the registry
March 27, 2025
CompletedFirst Posted
Study publicly available on registry
April 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 23, 2026
CompletedApril 9, 2025
April 1, 2025
2.5 years
March 27, 2025
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time Up and Go Test (TUG)
Time up and go test assess fall risk and measure the progress of balance, sit to stand and walking. Simple screening test that is a sensitive and specific measure of probability for falls among older adults. This test is intended to population affected by Parkinson's Disease, Multiple Sclerosis, Alzheimer's, Hip fracture, Total Knee Arthroplasty, Total Hip Replacement, Stroke and Huntington Disease. Materials needed consist in one chair with armrest, stopwatch and tape for mark 3 meters. Patients wear their regular footwear and can use a walking aid, if needed. The patient starts in a seated position and stands up upon therapist's command: walks 3 meters, turns around, walks back to the chair and sits down. The time stops when the patient is seated. Be sure to document the assistive device used. The score is calculated in seconds and high scores indicate an elevate risk of falling.
Day 0 (T0 - baseline), day 30 (T1 - After treatment).
Secondary Outcomes (8)
Cognitive Time Up and Go Test (TUG-C)
Day 0 (T0 - baseline), day 30 (T1 - After treatment).
Passive Range of Motion (p-ROM)
Day 0 (T0 - baseline), day 30 (T1 - After treatment).
Ten Meter Walking Test (10MWT)
Day 0 (T0 - baseline), day 30 (T1 - After treatment).
Hip Dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR).
Day 0 (T0 - baseline), day 30 (T1 - After treatment).
Medical Research Council Scale (MRC)
Day 0 (T0 - baseline), day 30 (T1 - After treatment).
- +3 more secondary outcomes
Other Outcomes (4)
Bilateral thigh cytometry.
Day 0 (T0 - baseline), day 30 (T1 - After treatment).
Number of falls in the last 3 months.
Day 0 (T0 - baseline), day 30 (T1 - After treatment) and day 120 (T2 - 3 months after treatment).
Client satisfaction questionnaire .
Day 30 (T1 - After treatment).
- +1 more other outcomes
Study Arms (2)
Experimental Group (EG)
EXPERIMENTALThe Experimental Group (EG) perform 30 minutes (16 sessions, 4 days/week, for 4 weeks) of balance rehabilitation exercises using non-immersive virtual reality with the OAK device (Khymeia Group, Italy).
Active comparator (CG)
ACTIVE COMPARATORPartecipants assigned to Control Group (CG) follow 30 minutes (4 days/week, for 4 weeks) of conventional rehabilitative treatments for balance without the use of technological devices.
Interventions
The intervention of the Experimental Group consists of 30 minutes (16 sessions, 4 days/week, for 4 weeks) of balance rehabilitation exercises using non-immersive virtual reality through the OAK device (Khymeia Group, Italy). The system includes exercises that require the patient to reach visual targets by shifting their Center of Pressure (COP). The exercises are categorized based on the direction of COP displacement and can be performed with increasing difficulty, as determined by the physiotherapist during the rehabilitation process.
Intervention of the Control Group (CG) consists of 30 minutes (4 days/week, for 4 weeks) of conventional balance rehabilitation treatments without the use of technological devices. The motor exercises will focus on the rehabilitation of balance, the trunk, and the lower limbs and will be carried out with a physiotherapist who will tailor the treatment according to the patient's characteristics and needs. Primary attention will be given to recovering trunk control and seated posture. This phase will focus on restoring and maintaining muscle trophism in the anterior and posterior kinetic chains of the thigh and lower leg, as well as the hip's range of motion, through isometric exercises and gentle joint mobilizations while adhering to anti-dislocation guidelines. The process will continue with the reacquisition of the upright stance, emphasizing proprioceptive, coordination, and balance abilities. Once the upright position is stabilized, gait re-education will be introduced.
Eligibility Criteria
You may qualify if:
- Age over 18 years;
- First elective hip arthroplasty;
- Cognitive ability to understand and perform the exercises outlined in the protocol;
- Ability to sign the informed consent.
You may not qualify if:
- Unable to adhere to the exercise program due to poor compliance;
- Previous contralateral hip arthroplasty;
- Surgical wound complications;
- Severe cognitive, linguistic, or visual impairments (inability to understand and follow the study procedures);
- Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons;
- Diagnosis of epilepsy;
- Presence of implanted cardiac pacemakers;
- Lack of signed informed consent for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IRCCS San Raffaele Romalead
- Ministero della Salute, Italycollaborator
Study Sites (2)
IRCCS San Raffaele Roma
Rome, Italy, 00163, Italy
Casa di Cura San Raffaele Sulmona
Sulmona, Italy, 67039, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Prof. Marco Franceschini, MD
IRCCS San Raffaele Roma
- PRINCIPAL INVESTIGATOR
Prof. Marco Franceschini, MD
IRCCS San Raffaele Roma
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- This study is assessor-blinded, meaning that the outcome assessors will be masked to group allocation to minimize bias in data collection and analysis. Other study personnel, including participants and intervention providers, will not be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2025
First Posted
April 3, 2025
Study Start
June 23, 2023
Primary Completion
December 31, 2025
Study Completion
March 23, 2026
Last Updated
April 9, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- IPD and supporting information will be available after official publication and upon request.
- Access Criteria
- Access will be granted upon specific request to the Study Chair, Principal Investigator, Sub-Investigator, or Central Study Contact Person. Researchers must submit a formal proposal outlining the intended use of the data, which will be reviewed for scientific merit and ethical compliance. Approved requests will receive access through a secure data-sharing platform.
De-identified individual participant data (IPD) related to primary and secondary outcome measures will be shared, including assessment results and relevant demographic data, in compliance with ethical and legal requirements.